12/23/2025
FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy: https://www.edwards.com/newsroom/news/2025-12-23-fda-approves-edwards-lifesciences--sapien-m3-mitra
Edwards Lifesciences is a global leader of patient-focused innovations for structural heart disease. All Terms and Conditions of Facebook apply.
One Edwards Way
Irvine, CA
92614
Be the first to know and let us send you an email when Edwards Lifesciences posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to Edwards Lifesciences: